HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
IONS
Ionis Pharmaceuticals Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $11.87B
Market Cap
$11.87B
Enterprise Val
$11.23B
P/E Ratio
-31.12
P/B Ratio
24.27
Trailing PEG (1Y)
-0.27
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$489.1M
Gross Margin96.09%
Profit Margin96.09%
Return on Equity-68.89%
Return on Assets-12.35%
Current Ratio3.83
Debt/Equity4.17
LT Debt/Equity3.29
Revenue Per Share1.26

Income Statement

Dec 31, 2025
Revenue$203.3M
Cost of Revenue$8.0M
Gross Profit$195.4M
R&D$279.6M
SG&A$130.2M
Operating Expenses$409.8M
Operating Income-$214.5M
Interest Expense$22.7M
Tax Expense$1.5M
Net Income-$229.4M
EPS (Basic)$-1.43
EPS (Diluted)$-1.43
EBIT-$205.2M
EBITDA-$197.9M
Consolidated Income-$229.4M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$372.3M
Accounts Receivable$66.1M
Inventory$10.0M
Current Assets$2.99B
LT Investments$0.00
Property, Plant & Equipment$361.6M
Intangibles$0.00
Non-Current Assets$533.2M
Total Assets$3.52B
Accounts Payable$28.1M
Current Debt$431.9M
Current Liabilities$781.6M
LT Debt$1.61B
Non-Current Liabilities$2.25B
Total Liabilities$3.03B
Total Debt$2.04B
Retained Earnings-$2.63B
Shareholder Equity$489.1M
Shares Outstanding161,974,393

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$137.7M
Investing Cash Flow-$419.5M
Financing Cash Flow$591.2M
CapEx-$21.3M
Free Cash Flow-$159.0M
Depreciation & Amort.$7.3M
Stock-Based Comp$43.3M
Acquisitions / Disposals$0.00
Investment Activity-$396.8M
Debt Issued/Repaid$483.4M
Equity Issued/Repaid$107.8M
Dividends Paid$0.00
Net Change in Cash$33.9M
Data cached · Meta live · Daily live · Statements live · TTL 24h